These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12937244)

  • 21. Antineutrophil cytoplasmic antibodies (ANCA) and small vessel vasculitis.
    Mareen P; Van De Walle S; Bernaert P; Vanhouteghem H; Dierick J
    Acta Clin Belg; 2003; 58(3):193-200. PubMed ID: 12945480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis und therapy of ANCA-associated vasculitis].
    Aries PM; Hellmich B; Gross WL
    Dtsch Med Wochenschr; 2006 Mar; 131(9):443-6. PubMed ID: 16493569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antineutrophil cytoplasmic antibody-associated vasculitides.
    Seo P; Stone JH
    Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis.
    Stegeman CA
    Nephrol Dial Transplant; 2002 Dec; 17(12):2077-80. PubMed ID: 12454214
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: a single-center experience.
    Stangou M; Asimaki A; Bamichas G; Christidou F; Zoumbaridis N; Natse T; Galanis N; Christaki P; Patakas D; Sombolos K
    J Nephrol; 2005; 18(1):35-44. PubMed ID: 15772921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of outcome in renal vasculitis.
    Jayne D
    Nephrology (Carlton); 2004 Oct; 9(5):254-5. PubMed ID: 15504135
    [No Abstract]   [Full Text] [Related]  

  • 27. [ANCA vasculitis].
    Bernis C
    Nefrologia; 2003; 23(2):103-6. PubMed ID: 12778872
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A child with panniculitis and microhaematuria/proteinuria--an unusual presentation of p-ANCA-positive vasculitis.
    Korzets Z; Pomeranz A; Bernheim J; Lazarov A; Wolach B; Bernheim J
    Nephrol Dial Transplant; 1997 Apr; 12(4):787-9. PubMed ID: 9141014
    [No Abstract]   [Full Text] [Related]  

  • 30. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
    Levine SM
    Ann Intern Med; 2010 Jan; 152(1):65; author reply 65. PubMed ID: 20048281
    [No Abstract]   [Full Text] [Related]  

  • 31. Potential immunosuppressive therapeutics to target small vessel vasculitis of the kidney.
    Williams JM
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1142-8. PubMed ID: 16312136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
    Keogh KA; Wylam ME; Stone JH; Specks U
    Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ANCA: anti-neutrophil cytoplasmic antibodies and their role in vasculitis associated kidney disorders.
    Badakere SS; Pradhan VD
    Indian J Med Sci; 2002 Jul; 56(7):335-9. PubMed ID: 12645170
    [No Abstract]   [Full Text] [Related]  

  • 34. Microscopic polyangiitis. A systemic vasculitis with a positive P-ANCA.
    Peñas PF; Porras JI; Fraga J; Bernis C; Sarriá C; Daudén E
    Br J Dermatol; 1996 Mar; 134(3):542-7. PubMed ID: 8731685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
    Lapraik C; Watts R; Bacon P; Carruthers D; Chakravarty K; D'Cruz D; Guillevin L; Harper L; Jayne D; Luqmani R; Mooney J; Scott D;
    Rheumatology (Oxford); 2007 Oct; 46(10):1615-6. PubMed ID: 17804455
    [No Abstract]   [Full Text] [Related]  

  • 36. Scleroderma associated with ANCA-associated vasculitis.
    Rho YH; Choi SJ; Lee YH; Ji JD; Song GG
    Rheumatol Int; 2006 Mar; 26(5):465-8. PubMed ID: 16012875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4. Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis: from molecular analysis to bedside.
    Yoshida M
    Intern Med; 2002 Jan; 41(1):47-9. PubMed ID: 11838592
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
    Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
    [No Abstract]   [Full Text] [Related]  

  • 39. Sustained monocyte activation in clinical remission of systemic vasculitis.
    Wikman A; Lundahl J; Jacobson SH
    Inflammation; 2008 Dec; 31(6):384-90. PubMed ID: 18846416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term data from the CYCLOPS study].
    Haubitz M
    Z Rheumatol; 2013 May; 72(4):402-3. PubMed ID: 23552980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.